arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

GT Biopharma, Inc.

GTBP

$4.51 ▼ -0.30 (-6.24%) at close

17 Visible periods

28 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, GT Biopharma, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $24.9M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -327.1% ↘

FCF / Share $-2.34 ↗

Trailing P/E —

Price / Book 38.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-28.35M

↓ -115.4% —

FCF / Share Free cash flow per share

$-2.34

↑ +65.6% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -327.1% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.46x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	N/M	-55.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-797%)	-83.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1143%)	7.6% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	1215.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15092%)	136.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1605%)	—	—
EPS Growth YoY (%)	3.7% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-23.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	71.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-854.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	39.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-115.4% Weak ↓ Weak Declining Year-over-year change in net income	-73.3% Weak ↓ Weak Declining Year-over-year change in net income	63.6% Excellent ↑ Excellent Improving Year-over-year change in net income	64.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-105.0% Weak ↓ Weak Declining Year-over-year change in net income	26.8% Excellent ↑ Excellent Improving Year-over-year change in net income	85.1% Excellent Excellent Year-over-year change in net income	-80.9% Weak Weak Year-over-year change in net income	N/M	N/M	-39.3% Weak ↑ Weak Improving Year-over-year change in net income	-4588.4% Weak ↓ Weak Declining Year-over-year change in net income	90.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-39.8% Weak Weak Year-over-year change in net income	-23.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	65.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-3.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	54.1% Excellent Excellent Year-over-year change in free cash flow	-2484.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	-57.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	32.9% Excellent Excellent Compound annual revenue growth over 3 years	222.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	—	—	—	—	19.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-215.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1537%)	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-136.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1235%)	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-120.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-289.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-327.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	679.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-143.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-143.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-207.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	83.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2199.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	49.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	8.1% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	55.5% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	77.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	36.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-287.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-339.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-96.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-127.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-178.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	119.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-4054.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-984.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-53.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37496.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16531.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-269.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-539.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1554.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3045.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1349.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	-101.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-777%)	-178.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1287%)	-264.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1865%)	95.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+534%)	200.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1234%)	—	-56.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-479%)	-51.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-444%)	52.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+253%)	79.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+429%)	7.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-47%)	81.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+444%)	72.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+384%)	54.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+265%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Interest Coverage (x)	—	—	-63.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2657.12x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-80.10x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	2.25x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-7.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-27.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.66x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.13x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.06x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-6.81M	$-3.95M	$-1.08M	$-5.67M	$-8.97M	$-5.30M	$-28.00K	$-60.00K	$-576.00K	$-19.00K	$-47.00K	$-855.00K	$-43.00K	$-61.00K	$-92.00K	$-54.00K	$-1.29M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	$0.00	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-6.68	$-6.94	$-5.64	$-19.66	$-2.06	—	—	$-5.16	$-8.54	$119.91	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.34	$-6.80	$-6.57	$-14.33	$-0.55	—	—	—	$-0.32	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.12	$-0.75	$5.41	$10.76	$0.68	$-5.71	$-0.28	$0.22	$5.02	$-181.58	$-25.76	$-12.50	$-0.01	$-0.01	$-0.02	$-0.04	—
Tangible Book Value per Share (USD)	$0.12	$-0.75	$5.41	$10.76	$0.68	$-5.71	$-0.28	$0.22	$5.02	$-181.58	$-25.76	$-12.50	$-0.01	$-0.01	$-0.02	$-0.04	—
Basic Weighted Avg Shares (shares)	5.51M	1.90M	1.35M	1.06M	28.16M	—	—	50,240	16.77M	81,460	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$5.79M	$-1.67M	$7.42M	$11.62M	$21.91M	$-29.43M	$-19.43M	$-13.94M	$-2.10M	$-18.93M	$-61.12M	$-28.95M	$-6.26M	$-6.36M	$-5.13M	$-5.52M	—
Total Equity (USD)	$3.00M	$-1.67M	$7.48M	$11.73M	$21.91M	$-29.78M	$-19.31M	$11.37M	$251.69M	$-18.92M	$-61.83M	$-29.57M	$-6.33M	$-6.34M	$-5.10M	$-5.47M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	$0.00	—	—	$0.00	$0.00	$27.00K	$61.00K	$368.00K	$342.00K	$26.00K	$11.00K	—
Depreciation Expense (USD)	—	—	—	—	—	$0.00	$4.00K	$7.00K	$2.00K	$1.00K	$2.00K	$0.00	—	—	—	—	—
Net Income, GAAP (USD)	$-28.35M	$-13.16M	$-7.60M	$-20.88M	$-58.01M	$-28.30M	$-38.65M	$-259.19M	$-143.25M	$9.77M	$-32.73M	$-23.49M	$-501.00K	$-5.17M	$-3.70M	$-3.00M	—
Operating Cash Flow (USD)	$-12.91M	$-12.90M	$-8.85M	$-15.22M	$-15.61M	$-7.26M	$-3.66M	$-10.68M	$-5.43M	$-1.93M	$-4.66M	$-1.75M	$-442.00K	$-987.00K	$-963.00K	$-1.53M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 65 quarters

GT Biopharma, Inc.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare GTBP with peers